Michael J. Banker

Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding

Michael J. Banker, Tracey Clark, John A. Williams · Journal of Pharmaceutical Sciences · 2003 · 303 citations

Life Sciences, Biochemistry, Dialysis +6

Discovery of Two Clinical Histamine H ₃ Receptor Antagonists: <i>trans</i> - <i>N</i> -Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and <i>trans</i> -3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]- <i>N</i> -(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)

Travis T. Wager, Betty Pettersen, Anne W. Schmidt et al. · Journal of Medicinal Chemistry · 2011 · 108 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Predicting safety toleration of pharmaceutical chemical leads: Cytotoxicity correlations to exploratory toxicity studies☆

John W. Benbow, Jiri Aubrecht, Michael J. Banker et al. · Toxicology Letters · 2010 · 53 citations

Pharmacy, Medicinal Chemistry, Toxicology +17

Mechanistic insights on clearance and inhibition discordance between liver microsomes and hepatocytes when clearance in liver microsomes is higher than in hepatocytes

Christopher Keefer, George Chang, Anthony Carlo et al. · European Journal of Pharmaceutical Sciences · 2020 · 38 citations

Pharmacy, Biochemistry, Pharmacokinetics +15

Problem Formulation and Option Assessment (PFOA) Linking Governance and Environmental Risk Assessment for Technologies: A Methodology for Problem Analysis of Nanotechnologies and Genetically Engineered Organisms

Kristen C. Nelson, David A. Andow, Michael J. Banker · The Journal of Law Medicine & Ethics · 2009 · 26 citations

Business, Biotechnology, Environmental Sciences +13